Detection method for cis-isomer in vitamin K2 medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 天津康鸿医药科技发展有限公司
- Publication Date
- 2009-07-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for detecting impurities in vitamin K2 drugs, in particular to a method for detecting cis-isomers in vitamin K2 drugs. Background technique
[0002] With the extension of human life span, population aging has brought new problems to human health. Osteoporosis and the fractures it causes rank seventh among the current common diseases, seriously threatening the health of middle-aged and elderly people.
[0003] Studies have confirmed that vitamin K2 drugs have osteogenic effects, promote calcium metabolism, and at the same time inhibit bone resorption caused by osteoclasts, thereby increasing bone density and preventing osteoporosis. Menatetrenone, as a kind of vitamin K2 drugs, has a strong procoagulant effect (approved in 1972 as a procoagulant drug). Menatetrenone also has two effects of promoting osteogenesis and inhibiting bone resorption. It can not only activate osteoblasts and promote calcification, but also in...